Abstract: The claimed invention provides real-time and subsequent analysis personalized user based health and wellness information for predictive Alzheimer's diagnosis information. Non-invasive techniques utilize saliva for body levels of wellness indicators and microRNA predictive markers which are coordinated over time. Saliva captured on lateral flow sample collection strips are real-time indicator reviewed and subsequently analyzed using optional traditional analytical chemistry techniques including liquid chromatography/mass spectrometry (LC/MS) and coordinated with time of administration with genetic sequence analysis to confirm related disease conditions. By using P4 (Participatory, Personalized, Predictive, and Preventive) health management techniques the patient determines if telltale correlative microRNA indicators are present.

Abstract: The claimed invention provides real-time and subsequent analysis personalized user based caradiac health and wellness detection information utilizing novel cardiac health markers including Troponin as well as TMAO. Non-invasive techniques utilize saliva for body levels of cardiac wellness indicators as well as pharmaceutical ingestion which are coordinated over time. Saliva captured on sample strips are real-time indicator reviewed and subsequently analyzed using traditional analytical chemistry techniques including liquid chromatography/mass spectrometry (LC/MS) and coordinated with time of administration with optional genetic sequence analysis to confirm related cardiac disease conditions. By using P4 (Participatory, Personalized, Predictive, and Preventive) health management techniques the patient determines if the pharmaceutical is having the correct and desired effect for maximum therapeutic benefit.

Abstract: The claimed invention provides real-time and subsequent analysis personalized user based health, wellness and pharmaceutical and illicit drug detection information. Non-invasive techniques utilize saliva for body levels of wellness indicators and pharmaceutical and illicit drug ingestion which are coordinated over time. Saliva captured on sample strips are real-time indicator reviewed and subsequently analyzed using traditional analytical chemistry techniques including liquid chromatography/mass spectrometry (LC/MS) and coordinated with time of administration with optional genetic sequence analysis to confirm related disease conditions. By using P4 (Participatory, Personalized, Predictive, and Preventive) health management techniques the patient determines if the pharmaceutical is having the correct and desired effect for maximum therapeutic benefit. While illustrative embodiments detecting Metformin and Keppra are provided the system has broad pharmaceutical and illicit drug monitoring applicability.

Abstract: The claimed invention relates to an enhanced mobile health detection and monitoring system utilizing non-invasive saliva screening of real-time health metrics coupled with remote deep analysis of body characteristics. Health information is derived from a combination of local chemical markers which are optically collected, locally reported and broadcast over a ‘cloud based’ internet data distribution system. The disclosed system, method and related device derives personal health and wellness information by combining saliva with disposable wellness indicators which are subsequently analyzed for pharmaceutical indicators as well as DNA, RNA and protein biomarkers to provide comprehensive wellness information.

Abstract: The invention provides aptamers capable of binding to the skeletal Troponin I protein useful as diagnostics of skeletal muscle damage in which the skeletal Troponin I protein has been implicated.